Texas Instruments Incorporated (TXN) Bundle
Cantor Fitzgerald Raises Texas Instruments Price Target to $190
Cantor Fitzgerald adjusted its price target for Texas Instruments (NASDAQ:TXN) to $190 from $170 on December 16, 2025. The firm maintained a Neutral rating on the semiconductor manufacturer, suggesting a hold position for investors despite the increased valuation outlook.
Shares of Texas Instruments (NASDAQ:TXN) were trading at $177.88 following the announcement, reflecting a 0.1% decrease. The stock has seen a daily range between $176 and $179.03. The company maintains a total market capitalization of approximately $161.6B USD.
- Price Target: $190
- Current Price: $177.88
- Market Capitalization: $161.6B
- 52-Week High: $221.69
- 52-Week Low: $139.95
Recent regulatory filings show Representative Julie Johnson sold between $1,001 and $15,000 of TXN stock on November 13, 2025. This transaction was executed through a Chase brokerage account as part of a broader divestment strategy. Further details on the company are available in the Texas Instruments financial summary and the TXN investor profile.
Texas Instruments specializes in analog and embedded processing products for the industrial, automotive, and consumer electronics markets. Information regarding the TXN history mission ownership and the TXN mission vision provides context on its market standing. The TXN financial health report outlines its current fiscal position relative to competitors like Intel and Qualcomm.
Texas Instruments Incorporated (TXN) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.